GlaxoSmithkline Consumer Healthcare Ltd:企業の戦略・SWOT・財務情報

◆英語タイトル:GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6121
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

GlaxoSmithkline Consumer Healthcare Ltd – Strategy, SWOT and Corporate Finance Report
Summary

GlaxoSmithkline Consumer Healthcare Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GlaxoSmithKline Consumer Healthcare Ltd (GSKCH), a subsidiary of GlaxoSmithKline plc is a manufacturer and marketer of nutritional and over the counter (OTC) medical products. The company manufactures and sells malt based food products, cereal based beverages, biscuits, protein rich food, and OTC pain relief balms and acidity relief products. GSKCH markets health drinks under the brands of Horlicks, Boost, Maltova and Viva; analgesics under Crocin and Eno brands; oral care products under Sensodyne and Parodontax brands; and rubefacients under Iodex brand. The company operates its manufacturing facilities in Nabha, Sonepat and Rajahmundry in India. GSKCH is headquartered in Gurgaon, Haryana, India.

Scope

- Detailed information on GlaxoSmithkline Consumer Healthcare Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GlaxoSmithkline Consumer Healthcare Ltd in the form of a SWOT analysis
- An in-depth view of the business model of GlaxoSmithkline Consumer Healthcare Ltd including a breakdown and examination of key business segments
- Intelligence on GlaxoSmithkline Consumer Healthcare Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GlaxoSmithkline Consumer Healthcare Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GlaxoSmithkline Consumer Healthcare Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GlaxoSmithkline Consumer Healthcare Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on GlaxoSmithkline Consumer Healthcare Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
GlaxoSmithkline Consumer Healthcare Ltd: Company Overview 9
GlaxoSmithkline Consumer Healthcare Ltd: Overview and Key Facts 9
GlaxoSmithkline Consumer Healthcare Ltd: Overview 9
GlaxoSmithkline Consumer Healthcare Ltd: Key Facts 9
GlaxoSmithkline Consumer Healthcare Ltd: Key Employees 11
GlaxoSmithkline Consumer Healthcare Ltd: Key Employee Biographies 13
GlaxoSmithkline Consumer Healthcare Ltd: Major Products and Services 14
GlaxoSmithkline Consumer Healthcare Ltd: Company History 15
GlaxoSmithkline Consumer Healthcare Ltd: Management Statement 17
GlaxoSmithkline Consumer Healthcare Ltd: Locations and Subsidiaries 19
GlaxoSmithkline Consumer Healthcare Ltd: Key Competitors 20
GlaxoSmithkline Consumer Healthcare Ltd: Company Analysis 21
GlaxoSmithkline Consumer Healthcare Ltd: Business Description 21
GlaxoSmithkline Consumer Healthcare Ltd: SWOT Analysis 23
GlaxoSmithkline Consumer Healthcare Ltd: SWOT Overview 23
GlaxoSmithkline Consumer Healthcare Ltd: Strengths 23
GlaxoSmithkline Consumer Healthcare Ltd: Weaknesses 24
GlaxoSmithkline Consumer Healthcare Ltd: Opportunities 24
GlaxoSmithkline Consumer Healthcare Ltd: Threats 25
GlaxoSmithkline Consumer Healthcare Ltd: Corporate Financial Deals Activity 27
GlaxoSmithkline Consumer Healthcare Ltd: Financial Deals Overview 27
GlaxoSmithkline Consumer Healthcare Ltd: Targets and Partners 29
GlaxoSmithkline Consumer Healthcare Ltd: Top Deals 2014 – 2018YTD* 30
GlaxoSmithkline Consumer Healthcare Ltd: Partnership 31
GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership 32
GlaxoSmithkline Consumer Healthcare Ltd: Recent Developments 33
GlaxoSmithkline Consumer Healthcare Ltd: News and Events Summary 33
GlaxoSmithkline Consumer Healthcare Ltd: Business Expansion 34
GlaxoSmithkline Consumer Healthcare Ltd: Corporate Governance 35
GlaxoSmithkline Consumer Healthcare Ltd: Financial Deals 36
GlaxoSmithkline Consumer Healthcare Ltd: Financial Performance 36
GlaxoSmithkline Consumer Healthcare Ltd: Market Developments 37
GlaxoSmithkline Consumer Healthcare Ltd: Strategy and Operations 37
Appendix 39
Contact Us 39
Methodology 39
About MarketLine 40

List of Tables
Table 1: GlaxoSmithkline Consumer Healthcare Ltd: Key Facts
Table 2: GlaxoSmithkline Consumer Healthcare Ltd: Key Employees
Table 3: GlaxoSmithkline Consumer Healthcare Ltd: Company History
Table 4: GlaxoSmithkline Consumer Healthcare Ltd: Locations and Subsidiaries
Table 5: GlaxoSmithkline Consumer Healthcare Ltd: Key Competitors
Table 6: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: GlaxoSmithkline Consumer Healthcare Ltd: Targets and Partners
Table 9: GlaxoSmithkline Consumer Healthcare Ltd: Top Deals 2014 - 2018YTD*
Table 10: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 11: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 12: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 13: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 14: GlaxoSmithkline Consumer Healthcare Ltd: News and Events Summary
Table 15: GlaxoSmithkline Consumer Healthcare Ltd: Business Expansion
Table 16: GlaxoSmithkline Consumer Healthcare Ltd: Corporate Governance
Table 17: GlaxoSmithkline Consumer Healthcare Ltd: Financial Deals
Table 18: GlaxoSmithkline Consumer Healthcare Ltd: Financial Performance
Table 19: GlaxoSmithkline Consumer Healthcare Ltd: Market Developments
Table 20: GlaxoSmithkline Consumer Healthcare Ltd: Strategy and Operations

List of Figures
Figure 1: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 4: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 5: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 6: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[GlaxoSmithkline Consumer Healthcare Ltd:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Braeburn Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Braeburn Pharmaceuticals Inc (Braeburn), a subsidiary of Apple Tree Partners is a pharmaceutical company that develops novel and long-acting implantable and injectable treatments.The company’s product pipeline includes Probuphine, CAM2038, BB-0417, BB-0817, BB-1216. Its Probuphine, is a a si …
  • Birdstep Technology ASA:企業のM&A・事業提携・投資動向
    Birdstep Technology ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Birdstep Technology ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Bet Shemesh Engines Holdings (1997) Ltd
    Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report Summary Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Peptilogics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Peptilogics Inc (Peptilogics) is an early-stage biotechnology company that develops novel peptide therapeutics. The company’s antibiotics address the epidemic of multidrug-resistant bacterial infections. Its products portfolio includes engineered Cationic Antibiotic Peptides (eCAP) technolog …
  • Reliance Steel & Aluminum Co
    Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Biomm SA (BIOM3):企業の財務・戦略的SWOT分析
    Summary Biomm SA (Biomm), formerly Savicevic Participacoes SA is a biopharmaceutical company that research, develops, produces and markets biomedicines. The company develops processes for the production of active pharmaceutical ingredients and enzymes used in the production of biofuels. It licenses …
  • MITIE Group plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ophthotech Corp (OPHT):製薬・医療:M&Aディール及び事業提携情報
    Summary Ophthotech Corp (Ophthotech) is a biopharmaceutical company that offers novel therapeutics to treat diseases of the back of the eye for age-related macular degeneration. The company’s products include Zimura, an anti-complemente is a central component of the complement cascade that is suppos …
  • Napp Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Napp Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Synthetic Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Synthetic Genomics Inc (Synthetic Genomics) is a provider of synthetic biology and synthetic genomics solutions. The company provides DNA synthesis services, instrumentation, reagents, and bioinformatics services and software packages, among others. It provides solutions in genomics research …
  • Tokio Marine Asia Pte. Ltd.:企業の戦略・SWOT・財務情報
    Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • PolyPid Ltd (POLY):医療機器:M&Aディール及び事業提携情報
    Summary PolyPid Ltd (PolyPid) is a pharmaceutical company that develops manufactures and commercializes therapies for the treatment of various medical conditions including infection, pain, inflammation and cancer. The company’s pipeline product candidates include D-Plex100, an antibiotic drug reserv …
  • Freudenberg & Co. Kommanditgesellschaft
    Freudenberg & Co. Kommanditgesellschaft - Strategy, SWOT and Corporate Finance Report Summary Freudenberg & Co. Kommanditgesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Worthington Industries Inc:戦略・SWOT・企業財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bounty Oil & Gas NL (BUY):石油・ガス:M&Aディール及び事業提携情報
    Summary Bounty Oil & Gas NL (Bounty) is an independent exploration and production company that acquires, explores and develops oil and natural gas assets and produces oil and natural gas. It also carries out marketing of oil and gas (petroleum). The company’s Australian Onshore properties include PR …
  • Jersey Oil and Gas Plc (JOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Jersey Oil and Gas Plc (Jersey Oil), formerly Trap Oil Group Plc is an upstream oil and gas exploration and production company. The company acquires, explores, develops and produces natural gas properties in the UK continental shelf. Its oil and gas properties include Homer Block, Cortina Bl …
  • Pyng Medical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pyng Medical Corp (Pyng Medical), a subsidiary of Teleflex Medical Canada Inc, is a medical device company that manufactures and markets trauma and resuscitation products. The company offers products such as fast1 intraosseous infusion system, fastresponder sternal intraosseous device, mat t …
  • G-III Apparel Group, Ltd.:企業の戦略・SWOT・財務分析
    G-III Apparel Group, Ltd. - Strategy, SWOT and Corporate Finance Report Summary G-III Apparel Group, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Habib Metropolitan Bank Limited:企業の戦略・SWOT・財務分析
    Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • RBS Wealth Management:企業の戦略・SWOT・財務情報
    RBS Wealth Management - Strategy, SWOT and Corporate Finance Report Summary RBS Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆